Search Results - "Collan, J."
-
1
EP-1352: Early clinical experience from MRI-only based radiotherapy of localised prostate cancer
Published in Radiotherapy and oncology (01-04-2016)Get full text
Journal Article -
2
PO-0906: Can signs of individual radiosensitivity be seen in salivary gland scintigraphy after head and neck radiotherapy?
Published in Radiotherapy and oncology (01-03-2013)Get full text
Journal Article -
3
-
4
Expression of CD11b/CD18 adhesion molecules on circulating phagocytes—a novel aid to diagnose infection in patients with cancer
Published in Supportive care in cancer (01-12-2008)“…Goals of work No blood marker available to date is useful for distinguishing infection-related from neoplasm-related fever. We evaluated the expression of the…”
Get full text
Journal Article -
5
Complement Activation in Circulation and Central Nervous System after Rituximab (Anti-CD20) Treatment of B-Cell Lymphoma
Published in Leukemia & lymphoma (2001)“…Rituximab (IDEC-C2B8, Mabthera®, Rituxan®), a chimeric monoclonal antibody against the B-cell specific CD20-antigen, has been demonstrated to be effective in…”
Get full text
Journal Article -
6
1H MRS studies in the Finnish boron neutron capture therapy project: Detection of 10B-carrier, l- p-boronophenylalanine-fructose
Published in European journal of radiology (01-11-2005)“…This article summarizes the current status of 1H MRS in detecting and quantifying a boron neutron capture therapy (BNCT) boron carrier, l-…”
Get full text
Journal Article -
7
C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer
Published in European journal of cancer (1990) (01-03-2002)“…Breast cancer patients with c-erbB-2-positive tumours seem to benefit from anthracycline-based adjuvant chemotherapy. The predictive value of c-erbB-2 for…”
Get full text
Journal Article -
8
EP-1989: Linear model for salivary gland dose dose response
Published in Radiotherapy and oncology (01-04-2018)Get full text
Journal Article -
9
Design and construction of shoulder recesses into the beam aperture shields for improved patient positioning at the FiR 1 BNCT facility
Published in Applied radiation and isotopes (01-11-2004)“…Improvements have been made at the FiR 1 BNCT facility to ease the positioning of the patient with a tumor in the head and neck region into a lateral neutron…”
Get full text
Journal Article -
10
PO-0714: Toxicity and Clinical Outcome of IMRT versus Conventional Radiation Therapy for Endometrial Cancer
Published in Radiotherapy and oncology (01-05-2017)Get full text
Journal Article -
11
Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function
Published in Radiotherapy and oncology (01-03-2005)“…To investigate the salivary gland function following intensity modulated radiotherapy (IMRT) for head and neck cancer. Seventeen patients with oropharyngeal (…”
Get full text
Journal Article -
12
Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer
Published in Radiotherapy and oncology (01-03-2006)“…The submandibular glands produce most of the unstimulated saliva output and are the key in prevention of radiation-related xerostomia. We investigated whether…”
Get full text
Journal Article -
13
A dosimetric study on the use of bolus materials for treatment of superficial tumors with BNCT
Published in Applied radiation and isotopes (01-11-2004)“…For treatment of superficially located tumors, such as head and neck cancers that invade the skin, the tumor dose may remain low on the skin when such tumors…”
Get full text
Journal Article -
14
-
15
Mouse pituitary adenylate cyclase-activating polypeptide (PACAP): gene, expression and novel splicing
Published in Molecular and cellular endocrinology (28-06-2002)“…PACAP is a conserved neuropeptide present in all vertebrates. In the mouse, the PACAP gene and various mRNAs have been isolated. To further characterize the…”
Get full text
Journal Article -
16
Direct complement lysis as a major effector mechanism in rituximab (anti-CD20) therapy of B cell lymphomas
Published in Immunopharmacology (01-08-2000)Get full text
Journal Article